SteriTrack’s Tractus™ Platform to be Optimized for Machine Learning using Azure, Microsoft’s Cloud Computing Platform
MOUNTAIN VIEW, CALIF. (PRWEB) JULY 05, 2019
SteriTrack Inc. is pleased to announce it is partnering with Microsoft to bring its patented Tractus™ Platform to governments around the world.
Powered by Microsoft Azure, the Tractus™ software and scanning solution will bring cutting edge technology and point of care solutions to operating theatres worldwide to address new global regulations mandating all medical devices and supplies be labeled with a unique device identifier (UDI).
SteriTrack hopes to further optimize the Tractus™ Software by using Microsoft Azure to help leverage the power of artificial intelligence and the cloud, to help improve patient safety. In addition to this, SteriTrack will leverage Microsoft Azure’s enterprise class security technologies to build a system that meets each customers security, privacy and compliance standards.
The Tractus™ Platform uses a machine learning reporting system that enables healthcare organizations to create reports and obtain immediate insight into cost, quality, and outcomes of care. This level of data transparency validates that medical device utilization is appropriate and being processed accurately.
Microsoft is a trusted partner to healthcare organisations all over the world and we are delighted to announce SteriTrack as an exciting new partner for us, as we continue to build and evolve Microsoft solutions specific to the healthcare industry.
Microsoft Azure provides SteriTrack with access to unprecedented storage and compute power that will enable it to provide data and real-time analytics in a manner that is easy to digest and process for healthcare professionals. The advancements SteriTrack is making in this area using the Azure platform ensures that clinicians and hospitals can better manage, control and facilitate the best patient outcomes.Paul Shanahan, Cloud and AI Business Group Lead, Microsoft Ireland
Regulations mandating UDI compliance have created a standard for device traceability, but existing methods of documentation have been subject to error resulting in high costs. To help adhere to the standard introduced by legislation passed in the U.S., and soon to be enforced in the EU as of November 2021, the Tractus™ Platform scans the UDI code and matches it with regulatory databases, such as the FDA medical device recall (MDR) database.
Before the device is used, both sterile packaged and hospital sterilized devices are tracked with Tractus™ in the operating theatre to check for product expiration and recalls, offering point-of-care solutions and keeping surgery staff informed on medical devices before used in a procedure. This technology offers a reliable alternative to the potential errors associated with manual entry in the operating room and effectively reduces documentation time spent by nursing staff during an ongoing surgery.
Going forward, SteriTrack is excited to offer its Tractus™ Platform on Microsoft Azure and will continue efforts to enhance the interface, functionality, and data reporting capabilities of the software to improve patient safety.
SteriTrack™ is a healthcare information technology company with proven experience in the healthcare industry. The Tractus™ Platform is the only fully integrated hardware and software Universal AIDC technology system which captures medical device UDI data in and out of the sterile field for real-time documentation and inventory management.
Our Tractus™ Platform and its patented scanning technology focuses on patient safety by leveraging UDI data in governmental databases, such as GUDID, FDA medical device recall (MDR) database, and Eudamed (once operational) for point-of-use interfacing to ensure medical device safety prior to use or implantation. Tractus™ securely shares utilization information with your EMR, and ERP systems to provide clear visibility into the procedural care area. Unlike other systems, SteriTrack provides cloud database services and machine-learning capabilities to support post-market surveillance of medical devices for development of patient care best practices and improved patient outcomes.